Live News EQUITY FLASH L impact Oct 30, 2026, 01:14 PM UTC Goldman Sachs Cuts Bristol-Myers Squibb Price Target to $61 From $63 Goldman Sachs adjusted its price target on Bristol-Myers Squibb to $61 from $63. BMY SquawkNews Desk